United States Transcatheter Mitral Valve Repair Devices Markets 2017-2018: MitraClip is the only TMVR device approved for use by the FDA

Abbott Laboratories' MitraClip is the only TMVR device approved for use by the FDA. The MitraClip procedure is based on the edge-to-edge surgical method of valve repair. In the MitraClip procedure, the steerable guide catheter is inserted into the femoral vein at the groin and provides a conduit to access the mitral valve. The clip delivery system delivers and deploys the MitraClip, which must be carefully timed by the physician but can be adjusted if the position is not desirable. This procedure is performed while the heart is still beating, without cardiopulmonary bypass or the need for a thoracotomy or sternotomy.

Abbott Laboratories' MitraClip is the only TMVR device approved for use by the FDA. The MitraClip procedure is based on the edge-to-edge surgical method of valve repair. In the MitraClip procedure, the steerable guide catheter is inserted into the femoral vein at the groin and provides a conduit to access the mitral valve. The clip delivery system delivers and deploys the MitraClip, which must be carefully timed by the physician but can be adjusted if the position is not desirable. This procedure is performed while the heart is still beating, without cardiopulmonary bypass or the need for a thoracotomy or sternotomy.

The human heart contains four valves: the mitral valve, tricuspid valve, aortic valve and pulmonary valve. The mitral valve is most prone to regurgitation, which is a condition where blood is funneled back into the left atrium of the heart. Mitral regurgitation (MR) can either be caused by a congenital defect or myxomatous degeneration of the valve. Individuals with MR can suffer from atrial fibrillation, heart muscle dysfunction and even sudden death caused by cardiac arrest. In the U.S., there are just over 4 million people that may have MR, with only a minority actually diagnosed. The standard of care for MR is open surgery and/or the use of annuloplasty rings.

Key Topics Covered:

Executive Summary

1. Research Methodology

2. Disease Overview

3. Product Portfolio

4. Transcatheter Mitral Valve Repair Device Market

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/wrqs4g/united_states?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716